Grown Rogue International (GRUSF) Cash & Equivalents Growth (3y) (2012 - 2023)
Grown Rogue International (GRUSF) Cash & Equivalents Growth (3y) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 20.41% |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | -2.73% |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 3.22% |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | -49.65% |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 36.93% |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 10.41% |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 3.03% |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 1.92% |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 65.82% |
| 10 | Grown Rogue International | - | - | 3.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2023 | 74.99% |
| Jul 31, 2023 | 259.74% |
| Apr 30, 2023 | 176.41% |
| Jan 31, 2023 | 196.63% |
| Oct 31, 2022 | -97.76% |
| Apr 30, 2022 | 51.11% |
| Jan 31, 2022 | 27.94% |
| Oct 31, 2021 | -40.60% |
| Jul 31, 2021 | 29.33% |
| Apr 30, 2021 | -24.05% |
| Jan 31, 2021 | -45.73% |
| Oct 31, 2020 | -21.67% |
| Aug 31, 2018 | -4.34% |
| May 31, 2018 | 370,246.21% |
| Feb 28, 2018 | 6.37% |
| Nov 30, 2017 | -69.94% |
| Aug 31, 2017 | -83.56% |
| May 31, 2017 | -78.64% |
| Feb 28, 2017 | 44.49% |
| Nov 30, 2016 | -31.81% |